Resumen

Objectives: To perform quantitative assessment of the patients’ expectations and satisfaction with cryolipolysis treatment at our facilities. Introduction: Recently, the development of noninvasive body contouring devices has been remarkable. Among them, cryolipolysis has played a major role in the dramatic expansion of the body contouring and body shaping. At our clinics, the number of cases of cryolipolysis has been increasing year by year. In 2023 (as of November 28), cryolipolysis cases have already reached a record high of 55,896, and our group owns 66 cryolipolysis devices nationwide. In response to such a situation, more trustable data of the patients’ expectations and satisfaction with cryolipolysis is needed. Materials / method: We started an investigation on the efficacy and safety of cryolipolysis in late June 2023, targeting cryolipolysis models (n = 1,000) at our clinics in Japan. The primary outcomes were adverse events (AEs) that occurred immediately after the procedure, 1 week, 1 month, and 3 months after the procedure, as well as the number of days required for the adverse events to disappear, patient satisfaction with pain, satisfaction with efficacy, and overall satisfaction. Results: Of 1,000 participants, the data of primary outcomes, AEs disappearing days, various patient satisfaction values etc. At the time of the presentation at IMCAS World Congress 2024, these data will be analyzed and reported with some literature reviews. Conclusion: Our investigations are ongoing, and we are going to gain further kinds of results from the study, which include not only patients’ satisfaction related data, but details of adverse events caused by cryolipolysis. They will be reported on and on in the future.